Private Equity 8 Hours

Last updated: June 23, 2026, 5:30 AM ET

Private Equity Dealmaking & Strategy

Private equity firms are exploring new growth avenues, with European businesses increasingly leveraging global hiring as a strategic imperative. In the healthcare sector, AI is accelerating drug discovery by enabling rapid screening of compounds, a development drawing significant private capital interest. This technological shift is also influencing healthtech startups, with Tandem Health CEO asserting independence from major AI providers, indicating a diverse approach to technology adoption within the sector. Meanwhile, investors are keenly watching the U.K. defense sector, where private capital is showing strong interest in national security plans.

Credit Market Activity

The private credit market is experiencing significant redemption pressures, as demonstrated by Apollo's flagship retail credit fund meeting only a small fraction of its quarterly exit requests. The fund's ability to satisfy just 5% of redemptions, with overall exits at 17%, signals a potential liquidity crunch for retail-focused debt vehicles facing investor demand for cash. This comes as private equity firms continue to navigate complex market conditions, seeking both new investments and managing existing portfolios.